Sanni Soderlund

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Angiopoietin-like protein 3 complete and partial deficiency markedly accelerates apolipoprotein B48 and B100 metabolism in triglyceride-rich lipoproteins in humans.

Angiopoietin-like protein 3 complete and partial deficiency markedly accelerates apolipoprotein B48 and B100 metabolism in triglyceride-rich lipoproteins in humans.

Journal: Journal of internal medicine

Published: June 11, 2026

Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humans.

Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humans.

Journal: Atherosclerosis

Published: January 15, 2025

Clinical significance of CYP11B2 immunostaining in unilateral primary aldosteronism.

Clinical significance of CYP11B2 immunostaining in unilateral primary aldosteronism.

Journal: Endocrine connections

Published: August 19, 2023

Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.

Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy.

Journal: Diabetologia

Published: March 23, 2023

Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations.

Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations.

Journal: JCI insight

Published: April 06, 2022

Role of endogenous incretins in the regulation of postprandial lipoprotein metabolism.

Role of endogenous incretins in the regulation of postprandial lipoprotein metabolism.

Journal: European journal of endocrinology

Published: November 29, 2021

Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans.

Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans.

Journal: Journal of internal medicine

Published: August 19, 2021

Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.

Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: December 28, 2020

Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetes.

Effects of liraglutide on the metabolism of triglyceride-rich lipoproteins in type 2 diabetes.

Journal: Diabetes, obesity & metabolism

Published: November 21, 2020

Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans.

Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans.

Journal: JCI insight

Published: September 08, 2020

Polygenic Hyperlipidemias and Coronary Artery Disease Risk.

Polygenic Hyperlipidemias and Coronary Artery Disease Risk.

Journal: Circulation. Genomic and precision medicine

Published: March 11, 2020

Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.

Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.

Journal: Journal of internal medicine

Published: December 18, 2019

Showing 1-12 of 33

Last Updated: 09/26/2026